PDF herunterladen
Thromb Haemost 2014; 111(01): 182
DOI: 10.1160/TH13-10-0824
Author Correspondence
Schattauer GmbH

“Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.” Reply to a comment by Geddings and Mackman

Carmen Hernandez
1   Servicio de Hematología, Complejo Hospitalario Universitario de Ourense, Spain
,
Carmen Roncal
2   Atherothrombosis Lab, CIMA, University of Navarra, Pamplona, Spain
,
Josune Orbe
2   Atherothrombosis Lab, CIMA, University of Navarra, Pamplona, Spain
,
José A. Páramo
2   Atherothrombosis Lab, CIMA, University of Navarra, Pamplona, Spain
3   Servicio de Hematología, Clínica Universidad de Navarra, Pamplona, Spain
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 08. Oktober 2013

Accepted: 08. Oktober 2013

Publikationsdatum:
21. November 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

 

 

  • References

  • 1 Geddings JE, Mackman N. Comment on “Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients”. Thromb Haemost 2014; 111: 180-181.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 2 Hernandez C, Orbe J, Roncal C. et al. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients. Thromb Haemost 2013; 110: 598-608.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 3 Combes V, Simon AC, Grau GE. et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102.
    CrossrefPubMedGoogle Scholar
  • 4 Key NS, Mackman N. Tissue factor and its measurement in whole blood, plasma, and micro-particles. Semin Thromb Hemost 2010; 36: 865-875.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 5 Gosk-Bierska I, Wysokinski W, Karnicki K. et al. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study. Int Angiol 2008; 27: 296-301.
    PubMedGoogle Scholar
  • 6 Kakkar AK, DeRuvo N, Chinswangwatanakul V. et al. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995; 346: 1004-1005.
    CrossrefPubMedGoogle Scholar
  • 7 Sase T, Wada H, Yamaguchi M. et al. Haemostatic abnormalities and thrombotic disorders in malignant lymphoma. Thromb Haemost 2005; 93: 153-159.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 8 Lacroix R, Plawinski L, Robert S. et al. Leukocyteand endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica 2012; 97: 1864-1872.
    CrossrefPubMedGoogle Scholar
  • 9 Lee RD, Barcel DA, Williams JC. et al. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res 2012; 129: 80-85.
    CrossrefPubMedGoogle Scholar